Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various hypersensitivity diseases in horses can be diagnosed and treated with methods like immunotherapy and medication, and early aggressive treatment is crucial for severe diseases like equine cutaneous pythiosis.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

A child with Sweet syndrome was found to have chronic granulomatous disease and improved with treatment.

Most children with MIS-C showed significant improvement by 6 months.

Sumatriptan injections, high-flow oxygen, and verapamil effectively treat cluster headaches.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Medicinal plants might help with post-COVID-19 issues, but more research is needed.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Hypoalbuminemia can cause pleural effusion and needs careful treatment.

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

COVID-19 infection can significantly cause temporary hair loss.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Forsythiaside A reduces kidney damage from sepsis by lowering inflammation and cell death.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.